Ñonditions and diseases


ALS
Alzheimer's Disease
Anemia
Anti-Aging Treatment
Arterial Hypertension
Autism
Cancer
Diabetes Treatment
Eye Diseases
HIV/AIDS
Idiopathic Encephalopathy
Ischemic Heart Disease
Liver Diseases
MD Treatment
Multiple Sclerosis Treatment
Parkinson Treatment
Rheumatoid Arthritis
SMA
Ulcerative Colitis. Crohn’s Disease
News about stem cells
Cloning Is Used to Create Embryonic Stem Cells
19 May 2013
Scientists have finally succeeded in using cloning to create human embryonic stem cells, a step toward developing replacement tissue to treat diseases.
University of Adelaide research raises hope for multiple sclerosis treatment
13 May 2013
The researchers hope using stem cells from fat tissue - to send cells with anti-inflammatory properties directly to the damaged site in the central nervous system - will be able to treat the autoimmune disease.
2-year-old girl gets windpipe made from stem cells
06 May 2013
A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.
All news

Parkinson Treatment


Parkinson TreatmentParkinson’s disease (PD) is a degenerative disorder of the central nervous system characterized by different neurological disturbances related to motor skills, balance, psychoemotional disturbances, cognitive impairment and social behavioral disorders. PD is a progressive disorder: with time the condition of the sufferer tends to gradually aggravate. PD incidence doesn’t depend on sex or race, social status or place of residence. Despite the prevailing opinion that PK is a disorder involving elderly people, the average age of PD diagnosis is 57 years. However, 10% of the diseased are people under 40. With the increase of life span and average age of the population the incidence of PD is expected to rise.

The symptoms of PD mainly result from degeneration of dopaminergic neurons – neurons of the brain that produce and accumulate dopamine. Dopamine is a neurotransmitter, i.e. chemical serving to relay electric impulses from neurons, and a hormone. Dopamine deficit results in impaired transmission of nervous impulses, thus causing such distinctive PD symptoms as tremor of hands and legs, jaws, facial muscles, slowed movements, muscle stiffness, difficulties to initiate a movement and keep balance. Losing expressed mimicry, PD patients can seem apathic (indifferent). Speech can become slurred and monotonous. Other PD symptoms include depression, anxiety, dementia (weakness of mind), difficulties in chewing and swallowing, appetite disturbances, hypersalivation, and bowel and urinary bladder disorders. Not all the above PD symptoms develop in each PD case.

The causes of PD have not been defined. Common causes of Parkinson’s diseases include combination of several factors, in particular:
  • aging. Age-related decrease of neurons number in the brain can be one of the PD causes;
  • genetics;
  • some toxins and chemicals. Described were several severe PD cases in young drug addicts who consumed synthetic heroin.
Other causes of PD include cerebral atherosclerosis, head trauma, tumours, virus infections, etc.

Due to commonly slow progression, Parkinson’s disease at its early stages can be difficult to diagnose for several years. Typically, at the initial stage of Parkinson’s disease patients complain of some rigidity in the extremities, decreased joint flexibility, difficulty in walking and performing active movements. It is worth noting that PD progresses more rapidly in those who developed it at younger age.

Depending on how PD progresses at the advanced stages, the quality of PD sufferers’ life can significantly deteriorate. In severe disorders, such as disturbed swallowing or total immobilization and in case of impropriate nursing, such concomitant problems as respiratory disturbances, secondary infection, etc., can develop. In average, Parkinson’s disease cuts down the life expectancy by 3-9 years.

Parkinson treament with stem cells


Cell Therapy Center EmCell offers Parkinson treatment with fetal stem cells. We have developed schemes of stem cell treatment for management and control of the disease, which has proven to be effective in case of different forms and at all stages of parkinsonism.

At stages I-III, when uni- and bilateral manifestations of the disease are observed, such as balance disturbances, tremor, mild and moderate rigidity, etc., administration of fetal stem cells is effective in 85% of cases. After the treatment, patients report improvement of stiffness, decrease in shaking while walking and tremor. The dose of antiparkinson drugs can be lowered.

At stage IV (severe stiffness, but the patient still can walk or stand unassisted), stem cell treatment is effective in 65-70% of Parkinson’s disease cases. At stage V (bed- or wheelchair-bound), our therapy helps to improve patient’s quality of life and ease care for the patient due to decreased spasticity and tremor syndrome and improved sleep, normalization of organ and system functioning (heart, lungs, bowels).

In 100% of cases, Parkinson treatment with fetal stem cells results in psychoemotional improvements. After the stem cell treatment, patients demonstrate positive emotions, improved thinking, more expressive, intelligible and louder speech, and more persistent memory and intellect.

The course of Parkinson treatment at Cell Therapy Center EmCell totals, as a rule, 2 days.

Testimonials

The letter from the wife of the patient with Parkinson's disease after the stem cell treatment
The letter from the patient with Parkinson’s disease, stage II after treatment at cell therapy center EmCell


Request additional information



Request info

English



News and articles about Parkinson Treatment

Stem cell transplant boosts function slightly in Parkinson's monkeys
08 December 2012
In a small but hopeful step for researchers working on therapies to treat Parkinson’s disease, a team in Japan has used stem cells harvested from bone marrow to restore function in monkeys with the debilitating condition.
Injecting Stem Cell Into The Brain Reduces Parkinson's Symptoms in Monkeys
24 March 2012
Human embryonic stem cells transplanted into the monkey brain reduced suffering in animals with Parkinson's disease-like symptoms, the study by researchers from Kyoto University in Japan demonstrates.
Stem Cell Studies Will Help Better Understand Parkinson’s and the Ways of Its Treatment
28 November 2011
Scientists from the University of Edinburgh and University College London have created brain nerve cells from the skin of the patient with rapidly progressing Parkinson’s disease.
Parkinson's Disease Reversed in Rat Models
27 May 2011
A joint team of researchers from Republic of Korea (Hanyang University) and the U.S. (Harvard Medical School) has identified the stem cell type that might be effective in treating Parkinson's.
All news about Parkinson Treatment


Anti-Aging Treatment
Contacts FAQs Congresses and Conferences